Phase I trial of Intranasal COVID 19 vaccine - Bharat Biotech/ Washington University School of Medicine.
Latest Information Update: 29 Sep 2020
At a glance
- Drugs OCU 500 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 29 Sep 2020 New trial record
- 22 Sep 2020 According to a Precision Virologics media release, this trial will take place at Saint Louis Universitys Vaccine and Treatment Evaluation Unit.